JP6499307B2 - 人工カプセルデバイス、システム、および方法 - Google Patents
人工カプセルデバイス、システム、および方法 Download PDFInfo
- Publication number
- JP6499307B2 JP6499307B2 JP2017542011A JP2017542011A JP6499307B2 JP 6499307 B2 JP6499307 B2 JP 6499307B2 JP 2017542011 A JP2017542011 A JP 2017542011A JP 2017542011 A JP2017542011 A JP 2017542011A JP 6499307 B2 JP6499307 B2 JP 6499307B2
- Authority
- JP
- Japan
- Prior art keywords
- artificial
- annular structure
- capsule
- flat side
- iol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims description 929
- 238000000034 method Methods 0.000 title description 136
- 239000000463 material Substances 0.000 claims description 206
- 239000004642 Polyimide Substances 0.000 claims description 41
- 229920001721 polyimide Polymers 0.000 claims description 41
- 229920001296 polysiloxane Polymers 0.000 claims description 40
- 210000001508 eye Anatomy 0.000 description 319
- 241001465754 Metazoa Species 0.000 description 77
- 241000283973 Oryctolagus cuniculus Species 0.000 description 70
- 210000000554 iris Anatomy 0.000 description 69
- 230000003287 optical effect Effects 0.000 description 65
- 238000012360 testing method Methods 0.000 description 62
- 230000005540 biological transmission Effects 0.000 description 54
- 239000003814 drug Substances 0.000 description 54
- 238000003780 insertion Methods 0.000 description 51
- 230000037431 insertion Effects 0.000 description 51
- 230000008569 process Effects 0.000 description 46
- 229940079593 drug Drugs 0.000 description 44
- 238000001356 surgical procedure Methods 0.000 description 44
- 230000015572 biosynthetic process Effects 0.000 description 42
- 230000000007 visual effect Effects 0.000 description 41
- 210000001747 pupil Anatomy 0.000 description 40
- 206010016654 Fibrosis Diseases 0.000 description 35
- 230000004761 fibrosis Effects 0.000 description 35
- 238000012384 transportation and delivery Methods 0.000 description 35
- 230000008901 benefit Effects 0.000 description 34
- 230000001886 ciliary effect Effects 0.000 description 30
- 239000007943 implant Substances 0.000 description 27
- 238000005516 engineering process Methods 0.000 description 26
- 210000001525 retina Anatomy 0.000 description 24
- 230000006870 function Effects 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 23
- 239000007924 injection Substances 0.000 description 22
- 238000002347 injection Methods 0.000 description 22
- 208000002177 Cataract Diseases 0.000 description 21
- 230000008602 contraction Effects 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 19
- 210000004087 cornea Anatomy 0.000 description 19
- 230000008878 coupling Effects 0.000 description 19
- 238000010168 coupling process Methods 0.000 description 19
- 238000005859 coupling reaction Methods 0.000 description 19
- 230000004438 eyesight Effects 0.000 description 19
- 239000008103 glucose Substances 0.000 description 19
- 238000011068 loading method Methods 0.000 description 19
- -1 polypropylene Polymers 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 230000003993 interaction Effects 0.000 description 16
- 238000000465 moulding Methods 0.000 description 16
- 230000002093 peripheral effect Effects 0.000 description 16
- 230000002829 reductive effect Effects 0.000 description 16
- 238000012790 confirmation Methods 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 13
- 238000002513 implantation Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- 201000009310 astigmatism Diseases 0.000 description 12
- 238000012377 drug delivery Methods 0.000 description 12
- 210000003786 sclera Anatomy 0.000 description 12
- 230000004308 accommodation Effects 0.000 description 11
- 210000001124 body fluid Anatomy 0.000 description 11
- 238000004891 communication Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000005286 illumination Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 11
- 239000004926 polymethyl methacrylate Substances 0.000 description 10
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 10
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 10
- 239000004810 polytetrafluoroethylene Substances 0.000 description 10
- 239000003190 viscoelastic substance Substances 0.000 description 10
- 238000004873 anchoring Methods 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 230000004410 intraocular pressure Effects 0.000 description 9
- 210000001542 lens epithelial cell Anatomy 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 210000004127 vitreous body Anatomy 0.000 description 9
- 102000009123 Fibrin Human genes 0.000 description 8
- 108010073385 Fibrin Proteins 0.000 description 8
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 8
- 230000004075 alteration Effects 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004240 ciliary body Anatomy 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 229950003499 fibrin Drugs 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 210000001742 aqueous humor Anatomy 0.000 description 7
- 230000003190 augmentative effect Effects 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 230000001788 irregular Effects 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 229920001155 polypropylene Polymers 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 6
- 210000002159 anterior chamber Anatomy 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000006196 drop Substances 0.000 description 6
- 210000002919 epithelial cell Anatomy 0.000 description 6
- 230000004424 eye movement Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 6
- 229910001000 nickel titanium Inorganic materials 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- 230000002980 postoperative effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000013268 sustained release Methods 0.000 description 6
- 239000012730 sustained-release form Substances 0.000 description 6
- 208000010412 Glaucoma Diseases 0.000 description 5
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 5
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
- 210000005252 bulbus oculi Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- IUWCPXJTIPQGTE-UHFFFAOYSA-N chromium cobalt Chemical compound [Cr].[Co].[Co].[Co] IUWCPXJTIPQGTE-UHFFFAOYSA-N 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 238000011982 device technology Methods 0.000 description 5
- 230000010339 dilation Effects 0.000 description 5
- 230000005611 electricity Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000012014 optical coherence tomography Methods 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 206010036346 Posterior capsule opacification Diseases 0.000 description 4
- 238000000692 Student's t-test Methods 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 239000000560 biocompatible material Substances 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000003844 drug implant Substances 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 208000002780 macular degeneration Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 208000001491 myopia Diseases 0.000 description 4
- 210000001328 optic nerve Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000012781 shape memory material Substances 0.000 description 4
- 229920000431 shape-memory polymer Polymers 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000012353 t test Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000004323 axial length Effects 0.000 description 3
- 229960000074 biopharmaceutical Drugs 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000029436 dilated pupil Diseases 0.000 description 3
- 229940068204 drug implant Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229960004716 idoxuridine Drugs 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000002262 irrigation Effects 0.000 description 3
- 238000003973 irrigation Methods 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000004118 muscle contraction Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000008177 pharmaceutical agent Substances 0.000 description 3
- 238000001259 photo etching Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000010344 pupil dilation Effects 0.000 description 3
- 208000014733 refractive error Diseases 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000009958 sewing Methods 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000004382 visual function Effects 0.000 description 3
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920000544 Gore-Tex Polymers 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- LRJOMUJRLNCICJ-JZYPGELDSA-N Prednisolone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O LRJOMUJRLNCICJ-JZYPGELDSA-N 0.000 description 2
- 208000002367 Retinal Perforations Diseases 0.000 description 2
- 206010038848 Retinal detachment Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 206010047663 Vitritis Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000008303 aniridia Diseases 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000003161 choroid Anatomy 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 235000012489 doughnuts Nutrition 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 230000005674 electromagnetic induction Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000003176 fibrotic effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229960001347 fluocinolone acetonide Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 2
- 230000004313 glare Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000013653 hyalitis Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960004184 ketamine hydrochloride Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000037323 metabolic rate Effects 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 2
- 229960001802 phenylephrine Drugs 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229960002800 prednisolone acetate Drugs 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000004264 retinal detachment Effects 0.000 description 2
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 208000029257 vision disease Diseases 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 2
- 229960001600 xylazine Drugs 0.000 description 2
- FAAHNQAYWKTLFD-UHFFFAOYSA-N 1-butan-2-ylpyrrolidin-2-one Chemical compound CCC(C)N1CCCC1=O FAAHNQAYWKTLFD-UHFFFAOYSA-N 0.000 description 1
- BFUUJUGQJUTPAF-UHFFFAOYSA-N 2-(3-amino-4-propoxybenzoyl)oxyethyl-diethylazanium;chloride Chemical compound [Cl-].CCCOC1=CC=C(C(=O)OCC[NH+](CC)CC)C=C1N BFUUJUGQJUTPAF-UHFFFAOYSA-N 0.000 description 1
- KKEBXNMGHUCPEZ-UHFFFAOYSA-N 4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one Chemical compound N1C(=O)N(CCS)CC1C1=CC=CC=C1 KKEBXNMGHUCPEZ-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010008398 Change in sustained attention Diseases 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011033 Corneal oedema Diseases 0.000 description 1
- 101001074449 Crotalus durissus terrificus Phospholipase A2 inhibitor CNF Proteins 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010048843 Cytomegalovirus chorioretinitis Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000238558 Eucarida Species 0.000 description 1
- 206010052128 Glare Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000003923 Hereditary Corneal Dystrophies Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000511976 Hoya Species 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000155250 Iole Species 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 241000158500 Platanus racemosa Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 208000002158 Proliferative Vitreoretinopathy Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 206010038897 Retinal tear Diseases 0.000 description 1
- 206010048955 Retinal toxicity Diseases 0.000 description 1
- 206010038934 Retinopathy proliferative Diseases 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 241000183290 Scleropages leichardti Species 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 241000278713 Theora Species 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 238000003302 UV-light treatment Methods 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002350 accommodative effect Effects 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229960002833 aflibercept Drugs 0.000 description 1
- 108010081667 aflibercept Proteins 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004329 axial myopia Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960002470 bimatoprost Drugs 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000011852 carbon nanoparticle Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 206010011005 corneal dystrophy Diseases 0.000 description 1
- 201000004778 corneal edema Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000001763 cytomegalovirus retinitis Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 208000029444 double vision Diseases 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000010393 epithelial cell migration Effects 0.000 description 1
- 230000008556 epithelial cell proliferation Effects 0.000 description 1
- 230000007705 epithelial mesenchymal transition Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical class N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000004886 head movement Effects 0.000 description 1
- 229940089982 healon Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 229940029200 iluvien Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940113601 irrigation solution Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 208000013469 light sensitivity Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 229940076783 lucentis Drugs 0.000 description 1
- 229940112534 lumigan Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 208000029233 macular holes Diseases 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- PQLXHQMOHUQAKB-UHFFFAOYSA-N miltefosine Chemical compound CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C PQLXHQMOHUQAKB-UHFFFAOYSA-N 0.000 description 1
- 230000003547 miosis Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000000651 myofibroblast Anatomy 0.000 description 1
- 229960002829 neomycin b sulfate Drugs 0.000 description 1
- 208000021971 neovascular inflammatory vitreoretinopathy Diseases 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000004493 normal intraocular pressure Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000020911 optic nerve disease Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229960003548 polymyxin b sulfate Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000006785 proliferative vitreoretinopathy Effects 0.000 description 1
- 229960001371 proparacaine hydrochloride Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940117392 provisc Drugs 0.000 description 1
- 230000004478 pupil constriction Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 229960003876 ranibizumab Drugs 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001927 retinal artery Anatomy 0.000 description 1
- 231100000385 retinal toxicity Toxicity 0.000 description 1
- 210000001957 retinal vein Anatomy 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 229940061341 retisert Drugs 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000009118 salvage therapy Methods 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 229940042596 viscoat Drugs 0.000 description 1
- 210000000857 visual cortex Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 229940053728 vitrasert Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1691—Packages or dispensers for intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1694—Capsular bag spreaders therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/1689—Intraocular lenses having supporting structure for lens, e.g. haptics having plate-haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/169—Surrounding optic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/16901—Supporting structure conforms to shape of capsular bag
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/16902—Separable from intraocular lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Prostheses (AREA)
Description
本願は、2015年12月14日に出願の米国特許出願第14/968,727号、2015年9月10日出願の米国仮特許出願第62/216,591、2015年5月29日出願の米国仮特許出願第62/168,493および2015年2月10日出願の米国仮特許出願62/114,231の優先権の利益を主張するものであり、そのそれぞれは、本明細書に参照によりその全体が組み入れられる。国外または国内の優先権に係る特許請求の範囲に関するいかなるおよびあらゆる出願は、本出願と共に提出される出願データシートにて特定され、37C.F.R1.57条の下、ここに参照により組み入れられる。
第5に、人工カプセルデバイス10は、術中に偽水晶体の屈折を生じさせることができ、その一方で、さらに、元々埋め込まれていたレンズを取り出すことなく別のIOLの埋め込みを可能にする。最近、IOL計算の方法論に進展があり、その方法論は、WaveTec ORAシステム、WaveTec OrangeシステムやClarity Medical Systems,Inc.からのHOLOS IntraOpなど、術中の屈折デバイスを使用して、良好な屈折結果を与えている。これらのデバイスは、無水晶体の屈折、偽水晶体の屈折、円環状IOL28の位置合わせを伴う補助、Limbal Relaxing Incisionsを伴う補助を実施することができる。無水晶体の屈折は、眼の内部にあるレンズを利用しないことから、ELPは、さらに、このデータが説明することができない変数である。偽水晶体の屈折は、有用である可能性があるが、IOL28が埋め込まれた後にのみ情報を提供するに過ぎない。種々のIOL28がさらに有益であることをデータが示す場合、医師は、有益性の低いIOL28を取り出して、より有益なIOL28を埋め込むことになる。IOL28の取り出しは、時間、手間、および技能を要し、天然カプセルバッグ24、小帯、角膜、および/または眼12内の他の構造体に損傷を与える原因となる可能性がある。人工カプセルデバイス10を、その後表面(例えば後部屈折面19)内に組み込んだ低出力レンズと共に使用することによって、医師が、この屈折面内での偽水晶体の屈折を実施することを可能にすることができ、さらに、医師が、人工カプセルデバイス10内に二次レンズ(例えばIOL28)を埋め込むことを可能にする。この二次レンズは、WaveTec ORAシステムやClarity HOLOSなどの術中の屈折デバイスによって測定された通りに屈折差を作り出す。
図11A〜11Cおよび11Eは、人工カプセルデバイス1100のさらに別の例を図説するものであり、ここでは、図11Aは側面図であり、図11Bは垂直断面図であり、図11Cは後方の平面図であり、図11Eは前方の側面斜視図である。図11Dは、人工カプセルデバイス1150のさらに別の例後方の平面図を示し、このデバイスは、以下にさらに詳細に記載されるように、屈折性部分を除いてデバイス1100と同様である。人工カプセルデバイス(例えばバッグ、ボウル、筐体、構造体、ケージ、フレーム)1100は、フランジを含まないか、またはフランジフリーであるが、フランジ(例えばフランジ20)と組み合わせることも可能である。デバイス1100は、後側部1102および前側部1104を含む。
図11Bおよび11Dに示すように、前側部1104は、開口1110を含み、この開口は、本明細書に議論されるようにIOLの挿入を可能にする。開口1110は、鋭い縁(例えば本明細書の他の実装例に示されるように)、丸い縁(例えば図11Bおよび11Eに示されるように)などを有していてもよい。鋭い縁は、素材の体積を低減し、より小さな切開を通じてデバイスを挿入することを可能にする。曲面は、鋭い面よりも光を伝送し易いことから、丸い縁を含む開口は、光の屈折を低減し、不要な反射または異常光視を阻害および防止する可能性がある。
電気システム
コンピューティング・システム・コンポーネント
コンピューティング・システム・デバイス/オペレーティング・システム
ネットワーク
ユーザ・アクセス・ポイント
他のシステム
Claims (24)
- 第1の素材を含む筐体構造であって、
第1の端部と、
第2の端部と
を含む第1の平坦側部;
第1の端部と、
第2の端部と
を含む、前記第1の平坦側部の反対側にある第2の平坦側部;
前記第1の平坦側部の前記第1の端部から前記第2の平坦側部の前記第1の端部の間に延在する、第3のアーチ側部;
前記第1の平坦側部の前記第2の端部から前記第2の平坦側部の前記第2の端部の間に延在する、前記第3のアーチ側部の反対側にある第4のアーチ側部;
屈折面と、
後部フィンと
を含む、後側部;
開口と、
前記開口の周囲の円形リップと
を含む、前記後側部の反対側にある前側部;および
縦軸
を含み、前記第1の平坦側部、前記第2の平坦側部、前記第3のアーチ側部、前記第4のアーチ側部、前記後側部、および前記前側部が、眼内デバイスを含有するように構成されている空洞を少なくとも部分的に規定する、筐体構造;ならびに
前記第1の素材とは異なる第2の素材を含み、前記縦軸を横切りかつ前記縦軸に沿う位置にある環状構造であって、
前記第1の平坦側部の前記第1の端部の直近から径方向外側に前記第1の平坦側部の前記第2の端部に向かって延在し、前記第1の平坦側部および前記第3のアーチ側部に固定されている、第1の環状構造部分;
前記第1の平坦側部の前記第2の端部の直近から径方向外側に前記第1の平坦側部の前記第1の端部に向かって延在し、前記第1の平坦側部および前記第4のアーチ側部に固定されている、第2の環状構造部分;
前記第2の平坦側部の前記第1の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在し、前記第2の平坦側部および前記第3のアーチ側部に固定されている、第3の環状構造部分;ならびに
前記第2の平坦側部の前記第2の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在し、前記第2の平坦側部および前記第4のアーチ側部に固定されている、第4の環状構造部分
を含み、前記第1の環状構造部分、前記第2の環状構造部分、前記第3の環状構造部分、および前記第4の環状構造部分のそれぞれは、末端部の直近に前方−後方の開口を含む、環状構造、
を含む、眼に挿入されるように構成されている人工カプセルデバイスであって、
前記筐体構造は、前記環状構造の固定点から径方向外側に延在する膨出をさらに含み、
前記第1の平坦側部、前記第2の平坦側部、前記第3のアーチ側部、および前記第4のアーチ側部のそれぞれは、
前記後側部から前記前側部に向かって少なくとも縦軸に沿う前記環状構造の位置まで前記縦軸と平行に延在する第1の部分と、
前記第1の部分から前記前側部のリップに向かって径方向内側に延在する第2の部分と
を含む、人工カプセルデバイス。 - 前記第1の素材は、シリコーンを含み、前記第2の素材は、ポリイミドを含む、請求項1に記載のデバイス。
- 前記屈折面は、−35Dから+35Dの間の屈折出力を有する、請求項1に記載のデバイス。
- 前記開口は、細長である、請求項1に記載のデバイス。
- 第1の端部と
第2の端部と
を含む第1の平坦側部;
第1の端部と、
第2の端部と
を含む、前記第1の平坦側部の反対側にある第2の平坦側部;
前記第1の平坦側部の前記第1の端部から前記第2の平坦側部の前記第1の端部の間に延在する、第3のアーチ側部;
前記第1の平坦側部の前記第2の端部から前記第2の平坦側部の前記第2の端部の間に延在する、前記第3のアーチ側部の反対側にある第4のアーチ側部;
屈折面を含む後側部;
開口を含む、前記後側部の反対側にある前側部;ならびに
縦軸
を含み、前記第1の平坦側部、前記第2の平坦側部、前記第3のアーチ側部、前記第4のアーチ側部、前記後側部、および前記前側部が、眼内デバイスを含有するように構成されている空洞を少なくとも部分的に規定する、筐体構造;ならびに
前記第1の平坦側部の前記第1の端部の直近から径方向外側に前記第1の平坦側部の前記第2の端部に向かって延在する、第1の環状構造部分;
前記第1の平坦側部の前記第2の端部の直近から径方向外側に前記第1の平坦側部の前記第1の端部に向かって延在する、第2の環状構造部分;
前記第2の平坦側部の前記第1の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在する、第3の環状構造部分;および
前記第2の平坦側部の前記第2の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在する、第4の環状構造部分
を含む、環状構造
を含む、眼に挿入されるように構成されている人工カプセルデバイス。 - 前記筐体構造は、第1の素材を含み、前記環状構造は、前記第1の素材とは異なる第2の素材を含む、請求項5に記載のデバイス。
- 前記第1の素材は、シリコーンを含み、前記第2の素材は、ポリイミドを含む、請求項6に記載のデバイス。
- 前記屈折面は、−35Dから+35Dの間の屈折出力を有する、請求項5に記載のデバイス。
- 前記第1の平坦側部、前記第2の平坦側部、前記第3のアーチ側部、および前記第4のアーチ側部のそれぞれは、前記後側部から前記前側部に向かって前記縦軸と平行に延在する第1の部分を含む、請求項5に記載のデバイス。
- 前記第1の平坦側部、前記第2の平坦側部、前記第3のアーチ側部、および前記第4のアーチ側部のそれぞれは、前記第1の部分から径方向内側に前記前側部の開口に向かって延在する第2の部分をさらに含む、請求項9に記載のデバイス。
- 前記筐体構造は、前記環状構造の固定点から径方向外側に延在する膨出部を含む、請求項5に記載のデバイス。
- 前記第1の環状構造部分、前記第2の環状構造部分、前記第3の環状構造部分、および第4の環状構造部分のそれぞれは、末端部の直近に前方−後方の開口を含む、請求項5に記載のデバイス。
- 第1の端部と
第2の端部と
を含む第1の側部;
第1の端部と、
第2の端部と
を含む、前記第1の側部の反対側にある第2の側部;;
前記第1の側部の前記第1の端部から前記第2の側部の前記第1の端部の間に延在する、第3の側部;
前記第1の側部の前記第2の端部から前記第2の側部の前記第2の端部の間に延在する、前記第3の側部の反対側にある第4の側部;
屈折面を含む後側部;
開口を含む、前記後側部の反対側にある前側部;ならびに
縦軸
を含み、前記第1の側部、前記第2の側部、前記第3の側部、前記第4の側部、前記後側部、および前記前側部が、眼内デバイスを含有するように構成されている空洞を少なくとも部分的に規定する、筐体構造;ならびに
前記第1の側部の前記第1の端部、前記第1の側部の第2の端部、前記第2の側部の前記第1の端部、および第2の側部の第2の端部のうち直近の1つから径方向外側に延在する環状構造部分を含む、環状構造
を含み、
前記筐体構造は、前記環状構造の固定点から径方向外側に延在する膨出部を含む、
眼に挿入されるように構成されている人工カプセルデバイス。 - 前記筐体構造は、第1の素材を含み、前記環状構造は、前記第1の素材とは異なる第2の素材を含む、請求項13に記載のデバイス。
- 前記第1の素材は、シリコーンを含み、前記第2の素材は、ポリイミドを含む、請求項14に記載のデバイス。
- 前記屈折面は、−35Dから+35Dの間の屈折出力を有する、請求項13に記載のデバイス。
- 前記開口は、細長である、請求項13に記載のデバイス。
- 前記開口の周囲にリップをさらに含む、請求項13に記載のデバイス。
- 前記第1の側部、前記第2の側部、前記第3の側部、および前記第4の側部のそれぞれは、前記後側部から前記前側部に向かって前記縦軸と平行に延在する第1の部分を含む、請求項13に記載のデバイス。
- 前記第1の側部、前記第2の側部、前記第3の側部、および前記第4の側部のそれぞれは、前記第1の部分から径方向内側に前記前側部の開口に向かって延在する第2の部分をさらに含む、請求項19に記載のデバイス。
- 前記後側部は、後部フィンを含む、請求項13に記載のデバイス。
- 前記環状構造は、前記環状構造部分を含む複数の環状構造部分を含む、請求項13に記載のデバイス。
- 前記環状構造部分は、前記第1の平坦側部の前記第1の端部の直近から径方向外側に前記第1の平坦側部の前記第2の端部に向かって延在する、第1の環状構造部分であって、前記複数の環状構造部分は、
前記第1の平坦側部の前記第2の端部の直近から径方向外側に前記第1の平坦側部の前記第1の端部に向かって延在する、第2の環状構造部分;
前記第2の平坦側部の前記第1の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在する、第3の環状構造部分;および
前記第2の平坦側部の前記第2の端部の直近から径方向外側に前記第2の平坦側部の前記第1の端部に向かって延在する、第4の環状構造部分
をさらに含む、請求項22に記載のデバイス。 - 前記構造部分は、末端部の直近に前方−後方の開口を含む、請求項13に記載のデバイス。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562114231P | 2015-02-10 | 2015-02-10 | |
US62/114,231 | 2015-02-10 | ||
US201562168493P | 2015-05-29 | 2015-05-29 | |
US62/168,493 | 2015-05-29 | ||
US201562216591P | 2015-09-10 | 2015-09-10 | |
US62/216,591 | 2015-09-10 | ||
US14/968,427 US9358103B1 (en) | 2015-02-10 | 2015-12-14 | Prosthetic capsular devices, systems, and methods |
US14/968,427 | 2015-12-14 | ||
PCT/US2015/065887 WO2016130209A1 (en) | 2015-02-10 | 2015-12-15 | Prosthetic capsular devices, systems, and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019046962A Division JP2019130329A (ja) | 2015-02-10 | 2019-03-14 | 人工カプセルデバイス、システム、および方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018512896A JP2018512896A (ja) | 2018-05-24 |
JP6499307B2 true JP6499307B2 (ja) | 2019-04-10 |
Family
ID=56082953
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017542011A Active JP6499307B2 (ja) | 2015-02-10 | 2015-12-15 | 人工カプセルデバイス、システム、および方法 |
JP2019046962A Pending JP2019130329A (ja) | 2015-02-10 | 2019-03-14 | 人工カプセルデバイス、システム、および方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019046962A Pending JP2019130329A (ja) | 2015-02-10 | 2019-03-14 | 人工カプセルデバイス、システム、および方法 |
Country Status (6)
Country | Link |
---|---|
US (13) | US9358103B1 (ja) |
EP (1) | EP3256072A4 (ja) |
JP (2) | JP6499307B2 (ja) |
AU (5) | AU2015382334B2 (ja) |
CA (2) | CA2972030C (ja) |
WO (1) | WO2016130209A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357620B1 (en) | 2021-09-10 | 2022-06-14 | California LASIK & Eye, Inc. | Exchangeable optics and therapeutics |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2970433T3 (es) | 2009-08-13 | 2024-05-28 | Acufocus Inc | Método de fabricación de implantes intraoculares con máscara y lentes |
US10004593B2 (en) | 2009-08-13 | 2018-06-26 | Acufocus, Inc. | Intraocular lens with elastic mask |
CN102883682A (zh) | 2010-04-27 | 2013-01-16 | 雷恩斯根公司 | 调节眼内晶状体的装置 |
US10278810B2 (en) | 2010-04-29 | 2019-05-07 | Ojo, Llc | Injectable physiologically adaptive intraocular lenses (IOL's) |
WO2012106673A1 (en) | 2011-02-04 | 2012-08-09 | Forsight Labs, Llc | Intraocular accommodating lens |
US9364316B1 (en) | 2012-01-24 | 2016-06-14 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
EP3915519A1 (en) | 2012-01-24 | 2021-12-01 | The Regents of the University of Colorado, a body corporate | Modular intraocular lens designs |
US10080648B2 (en) | 2012-01-24 | 2018-09-25 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US10028824B2 (en) | 2012-01-24 | 2018-07-24 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US8900300B1 (en) | 2012-02-22 | 2014-12-02 | Omega Ophthalmics Llc | Prosthetic capsular bag and method of inserting the same |
US20140088372A1 (en) * | 2012-09-25 | 2014-03-27 | Google Inc. | Information processing method |
WO2015066502A1 (en) | 2013-11-01 | 2015-05-07 | Thomas Silvestrini | Accomodating intraocular lens device |
EP3977962A1 (en) | 2013-11-01 | 2022-04-06 | Lensgen, Inc. | Two-part accomodating intraocular lens device |
AU2015219461B2 (en) | 2014-02-18 | 2019-10-31 | Alcon Inc. | Modular intraocular lens designs, tools and methods |
US10285805B2 (en) | 2014-03-28 | 2019-05-14 | Forsight Labs, Llc | Accommodating intraocular lens |
CA2952809C (en) | 2014-06-19 | 2019-11-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
US10647831B2 (en) | 2014-09-23 | 2020-05-12 | LensGens, Inc. | Polymeric material for accommodating intraocular lenses |
US10709551B2 (en) | 2014-12-27 | 2020-07-14 | Jitander Dudee | Accommodating intraocular lens assembly |
EP3250152A1 (en) | 2015-01-30 | 2017-12-06 | Clarvista Medical, Inc. | Modular intraocular lens designs |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US10413182B2 (en) * | 2015-07-24 | 2019-09-17 | Johnson & Johnson Vision Care, Inc. | Biomedical devices for biometric based information communication |
CA3002085A1 (en) | 2015-11-04 | 2017-05-11 | The Regents Of The University Of Colorado, A Body Corporate | Modular intraocular lens designs, tools and methods |
WO2017087888A1 (en) | 2015-11-18 | 2017-05-26 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
US11464625B2 (en) * | 2015-11-24 | 2022-10-11 | Acufocus, Inc. | Toric small aperture intraocular lens with extended depth of focus |
CN108778185B (zh) | 2015-12-01 | 2021-04-27 | 雷恩斯根公司 | 调节性人工晶状体装置 |
US11045309B2 (en) | 2016-05-05 | 2021-06-29 | The Regents Of The University Of Colorado | Intraocular lens designs for improved stability |
KR102609450B1 (ko) * | 2016-05-09 | 2023-12-04 | 삼성전자주식회사 | 전자 장치 및 전자 장치의 전자 문서 출력 방법 |
WO2017205811A1 (en) | 2016-05-27 | 2017-11-30 | Thomas Silvestrini | Lens oil having a narrow molecular weight distribution for intraocular lens devices |
CA3024891A1 (en) | 2016-05-31 | 2017-12-07 | Qura, Inc. | Implantable intraocular pressure sensors and methods of use |
WO2017213980A1 (en) | 2016-06-06 | 2017-12-14 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US10650621B1 (en) | 2016-09-13 | 2020-05-12 | Iocurrents, Inc. | Interfacing with a vehicular controller area network |
CA3040281C (en) | 2016-10-21 | 2021-04-13 | Omega Ophthalmics Llc | Prosthetic capsular devices |
WO2018081595A1 (en) | 2016-10-28 | 2018-05-03 | Forsight Vision6, Inc. | Accommodating intraocular lens and methods of implantation |
EP3574361B1 (en) * | 2017-01-30 | 2022-04-20 | Alcon Inc. | Systems and method for augmented reality ophthalmic surgical microscope projection |
US11382736B2 (en) | 2017-06-27 | 2022-07-12 | Alcon Inc. | Injector, intraocular lens system, and related methods |
JP2020526275A (ja) * | 2017-07-05 | 2020-08-31 | アキュフォーカス・インコーポレーテッド | 保護レンズホルダ |
US20210059810A1 (en) * | 2017-09-05 | 2021-03-04 | The Johns Hopkins University | Implantable lens capsule for intraocular lens insertion |
EP3681438A1 (en) | 2017-09-11 | 2020-07-22 | AMO Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
US11304796B2 (en) * | 2017-09-25 | 2022-04-19 | Verily Life Sciences Llc | Reinforcement ring for intraocular lens |
US10874549B2 (en) * | 2017-10-04 | 2020-12-29 | Johnson & Johnson Surgical Vision, Inc. | Electronic guillotine vitrectomy cutter |
RU2700131C2 (ru) * | 2017-11-13 | 2019-09-12 | Сергей Леонидович Кузнецов | Бифокальная оптическая система (биос) |
US11076946B2 (en) | 2017-11-16 | 2021-08-03 | Verily Life Sciences Llc | Flexible barrier layer including superelastic alloys |
DE102017221476A1 (de) * | 2017-11-29 | 2019-05-29 | AMIPLANT GmbH | Anordnung zur Implantation in den Sulcus Ciliaris |
CN107928869A (zh) * | 2017-12-07 | 2018-04-20 | 胡园园 | 一种人工囊袋 |
AU2019249216B2 (en) | 2018-04-06 | 2024-07-18 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
WO2019217471A1 (en) | 2018-05-09 | 2019-11-14 | Acufocus, Inc. | Intraocular implant with removable optic |
KR102162649B1 (ko) * | 2018-05-18 | 2020-10-07 | 연세대학교 산학협력단 | 연성 인공수정체낭 및 그 제조방법 |
JP2021532853A (ja) | 2018-07-23 | 2021-12-02 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド,ア ボディ コーポレイト | 薬物送達のための眼科用装置 |
US20210307609A1 (en) * | 2018-07-25 | 2021-10-07 | Qura, Inc. | Implantable intraocular pressure sensors configured as capsular tension rings |
US11806278B2 (en) | 2018-08-30 | 2023-11-07 | Qura, Inc. | Implantable intraocular drug delivery devices |
CA3121279A1 (en) * | 2018-11-30 | 2020-06-04 | Joseph J.K. MA | Ocular systems, devices, and methods |
BR102019001953A2 (pt) * | 2019-01-30 | 2020-08-11 | Márcio Prestes Lenharo | Dispositivo capsular protético e seu uso |
WO2021016678A1 (pt) * | 2019-07-26 | 2021-02-04 | Canhestro Neves Rafael | Saco capsular artificial |
WO2021061852A1 (en) * | 2019-09-23 | 2021-04-01 | Ojo, Llc | Injectable physiologically adaptive intraocular lens |
DE102019134301A1 (de) * | 2019-12-13 | 2021-06-17 | Carl Zeiss Meditec Ag | Ophthalmologisches Implantat |
AU2021227204A1 (en) * | 2020-02-24 | 2022-09-15 | SpyGlass Pharma, Inc. | Intraocular drug delivery platform |
EP4099968A4 (en) * | 2020-03-23 | 2024-03-06 | Tectus Corporation | ELECTRONIC INTRAOCULAR DEVICES |
WO2021194960A2 (en) * | 2020-03-23 | 2021-09-30 | Tectus Corporation | Electronic intraocular devices |
WO2021195244A1 (en) * | 2020-03-25 | 2021-09-30 | University Of South Florida | Intraocular lens repositioning device |
US11759309B2 (en) | 2020-04-29 | 2023-09-19 | Long Bridge Medical, Inc. | Devices to support and position an intraocular lens within the eye and methods of use |
US11399977B2 (en) | 2020-06-04 | 2022-08-02 | SpyGlass Pharma, Inc. | Ophthalmic implant system for drug delivery |
AU2021322289A1 (en) * | 2020-08-07 | 2023-03-02 | Long Bridge Medical, Inc. | Devices to support and position an intraocular lens within the eye and methods of use |
EP4225211A1 (en) | 2020-10-12 | 2023-08-16 | Omega Ophthalmics LLC | Prosthetic capsular devices, systems, and methods |
US20220233304A1 (en) * | 2021-01-25 | 2022-07-28 | Mark Michael Femandez | Method of surgically implanting an intraocular lens (iol) using a capsular prosthesis to support posterior chamber fixation |
DE102021118003A1 (de) | 2021-07-13 | 2023-01-19 | Carl Zeiss Meditec Ag | Künstliche Augenlinse mit integrierter Bildprojektionsvorrichtung, elektronisches Informationssystem und Verfahren |
WO2023139589A1 (en) * | 2022-01-24 | 2023-07-27 | Eyemed Technologies Ltd | Intraocular lens holding devices |
CN114504428B (zh) * | 2022-01-29 | 2024-05-24 | 中国人民解放军总医院第一医学中心 | 人工囊袋及其植入器械与方法 |
IL296395B1 (en) * | 2022-09-12 | 2024-06-01 | Eyemed Tech Ltd | Devices for maintaining an intraocular lens along the optical axis |
US20240180691A1 (en) * | 2022-11-17 | 2024-06-06 | Long Bridge Medical, Inc. | Ocular implant support devices and methods of use |
Family Cites Families (289)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073014A (en) | 1976-05-28 | 1978-02-14 | Stanley Poler | Intra-ocular lens |
JPS5785678A (en) | 1980-11-14 | 1982-05-28 | Mitsubishi Heavy Ind Ltd | Welding torch gaseous lens |
US4373218A (en) | 1980-11-17 | 1983-02-15 | Schachar Ronald A | Variable power intraocular lens and method of implanting into the posterior chamber |
EP0060732A3 (en) | 1981-03-18 | 1983-03-23 | KABUSHIKI KAISHA KOBE SEIKO SHO also known as Kobe Steel Ltd. | Controlled cooling apparatus for a wire rod |
US4402579A (en) | 1981-07-29 | 1983-09-06 | Lynell Medical Technology Inc. | Contact-lens construction |
US4435856A (en) | 1982-04-14 | 1984-03-13 | Esperance Francis A L | Bifocal intraocular lens structure and spectacle actuation frame |
US4585456A (en) | 1984-03-12 | 1986-04-29 | Ioptex Inc. | Corrective lens for the natural lens of the eye |
US4575373A (en) | 1984-11-02 | 1986-03-11 | Johnson Don R | Laser adjustable intraocular lens and method of altering lens power |
US4629461A (en) | 1984-11-05 | 1986-12-16 | Henry Clayman | Posterior chamber intra-ocular lens |
US4704124A (en) | 1985-01-22 | 1987-11-03 | Shearing Steven P | Intraocular lens |
US4731078A (en) | 1985-08-21 | 1988-03-15 | Kingston Technologies Limited Partnership | Intraocular lens |
US4685921A (en) | 1986-02-24 | 1987-08-11 | Peyman Gholam A | Variable refractive power, expandable intraocular lenses |
JPH0211134Y2 (ja) | 1986-07-14 | 1990-03-20 | ||
JPS6389154A (ja) * | 1986-10-03 | 1988-04-20 | 財団法人 臨床眼科研究所 | 白内障用眼内レンズ構造 |
US4842601A (en) | 1987-05-18 | 1989-06-27 | Smith S Gregory | Accommodating intraocular lens and method of implanting and using same |
US4769035A (en) | 1987-06-02 | 1988-09-06 | Kelman Charles D | Artificial lens and the method for implanting such lens |
US4888012A (en) | 1988-01-14 | 1989-12-19 | Gerald Horn | Intraocular lens assemblies |
US4816031A (en) | 1988-01-29 | 1989-03-28 | Pfoff David S | Intraocular lens system |
US4888016A (en) * | 1988-02-10 | 1989-12-19 | Langerman David W | "Spare parts" for use in ophthalmic surgical procedures |
US4833890A (en) * | 1988-04-04 | 1989-05-30 | Kelman Charles D | Bipartite intraocular lens |
CS271606B1 (en) | 1988-04-11 | 1990-10-12 | Sulc Jiri | Intraocular optical system |
US4932966A (en) | 1988-08-15 | 1990-06-12 | Storz Instrument Company | Accommodating intraocular lens |
US4892543A (en) | 1989-02-02 | 1990-01-09 | Turley Dana F | Intraocular lens providing accomodation |
US5358520A (en) | 1989-04-28 | 1994-10-25 | Nestle S.A. | Supplementary intraocular lens system |
US5476514A (en) | 1990-04-27 | 1995-12-19 | Cumming; J. Stuart | Accommodating intraocular lens |
US5171266A (en) | 1990-09-04 | 1992-12-15 | Wiley Robert G | Variable power intraocular lens with astigmatism correction |
US5203788A (en) | 1991-03-14 | 1993-04-20 | Wiley Robert G | Micromotor actuated adjustable focus lens |
US5147395A (en) * | 1991-07-16 | 1992-09-15 | Allergan Inc. | Small incision endocapsulator IOL |
US5180390A (en) * | 1991-07-30 | 1993-01-19 | Drews Robert C | Intraocular lens with reinforcing element |
US5326347A (en) | 1991-08-12 | 1994-07-05 | Cumming J Stuart | Intraocular implants |
US5222981A (en) | 1991-08-15 | 1993-06-29 | Werblin Research & Development Corp. | Multi-component intraocular lens |
US5275623A (en) | 1991-11-18 | 1994-01-04 | Faezeh Sarfarazi | Elliptical accommodative intraocular lens for small incision surgery |
US6322589B1 (en) | 1995-10-06 | 2001-11-27 | J. Stuart Cumming | Intraocular lenses with fixated haptics |
US5676669A (en) | 1993-04-30 | 1997-10-14 | Colvard; Michael | Intraocular capsular shield |
US5702402A (en) | 1994-04-29 | 1997-12-30 | Allergal | Method and apparatus for folding of intraocular lens |
DE4340205C1 (de) | 1993-11-25 | 1995-04-20 | Dieter W Klaas | Intraokularlinse mit einer Akkomodationseinrichtung |
US5697973A (en) | 1994-09-19 | 1997-12-16 | Peyman; Gholam A. | Intraocular silicone lens |
US5653751A (en) | 1994-12-07 | 1997-08-05 | Samiy; Nassrollah | Systems and methods for projecting an image onto a retina |
US5628795A (en) | 1995-03-15 | 1997-05-13 | Langerman David W | Spare parts for use in ophthalmic surgical procedures |
US5968094A (en) | 1995-09-18 | 1999-10-19 | Emmetropia, Inc. | Compound intraocular lens |
JP3747386B2 (ja) * | 1995-12-18 | 2006-02-22 | デイヴィッド・ダブリュ・ランガーマン | 後部被膜の混濁化抑制装置 |
US5728155A (en) | 1996-01-22 | 1998-03-17 | Quantum Solutions, Inc. | Adjustable intraocular lens |
US5984962A (en) | 1996-01-22 | 1999-11-16 | Quantum Vision, Inc. | Adjustable intraocular lens |
JP2000503867A (ja) | 1996-01-26 | 2000-04-04 | ビジョン・ファーマシューティカルズ・リミテッド・パートナーシップ | 主眼内レンズおよび補助眼内レンズシステム |
US20040148022A1 (en) | 1996-03-18 | 2004-07-29 | Eggleston Harry C. | Modular intraocular implant |
US20090005864A1 (en) | 1996-03-18 | 2009-01-01 | Eggleston Harry C | Modular intraocular implant |
US5800533A (en) | 1996-03-18 | 1998-09-01 | Harry C. Eggleston | Adjustable intraocular lens implant with magnetic adjustment facilities |
US5628798A (en) | 1996-03-18 | 1997-05-13 | Harry C. Eggleston | Adjustable and removable intraocular lens implant |
US20020128710A1 (en) | 1996-03-18 | 2002-09-12 | Eggleston Harry C. | Modular intraocular implant |
US6015435A (en) | 1996-10-24 | 2000-01-18 | International Vision, Inc. | Self-centering phakic intraocular lens |
US20050107875A1 (en) | 1997-05-20 | 2005-05-19 | Eyeonics, Inc. | Accommodating lens with haptics |
IL121417A0 (en) | 1997-07-28 | 1998-01-04 | Israel Henry M | Intraocular ring |
US8663235B2 (en) | 1997-10-14 | 2014-03-04 | Marie-José B. Tassignon | Bag-in-the-lens intraocular lens with removable optic |
US6027531A (en) | 1997-10-14 | 2000-02-22 | Tassignon; Marie-Joseb. R. | Intraocular lens and method for preventing secondary opacification |
DE69837818T2 (de) | 1997-11-12 | 2008-01-31 | Bausch & Lomb Inc. | Reinigung und desinfektion von kontaktlinsen mit einem biguanid und einem borat-phosphat-puffer |
US6066171A (en) | 1998-06-01 | 2000-05-23 | Visioncare Ltd. | Intraocular lens with pivoting telescope |
US6231603B1 (en) | 1998-11-10 | 2001-05-15 | Allergan Sales, Inc. | Accommodating multifocal intraocular lens |
US6117171A (en) | 1998-12-23 | 2000-09-12 | Skottun; Bernt Christian | Encapsulated accommodating intraocular lens |
US20050099597A1 (en) | 2002-12-24 | 2005-05-12 | Calhoun Vision | Light adjustable multifocal lenses |
US6450642B1 (en) | 1999-01-12 | 2002-09-17 | California Institute Of Technology | Lenses capable of post-fabrication power modification |
US20030128336A1 (en) | 2001-12-28 | 2003-07-10 | Jethmalani Jagdish M. | Customized lenses |
US7281795B2 (en) | 1999-01-12 | 2007-10-16 | Calhoun Vision, Inc. | Light adjustable multifocal lenses |
US20030151831A1 (en) | 2001-12-28 | 2003-08-14 | Sandstedt Christian A. | Light adjustable multifocal lenses |
US6537281B1 (en) | 1999-03-22 | 2003-03-25 | Valdemar Portney | Corrective intraocular lens system, intraocular lenses, and lens handling and installation devices for use therewith |
US7662179B2 (en) | 1999-04-09 | 2010-02-16 | Sarfarazi Faezeh M | Haptics for accommodative intraocular lens system |
US8556967B2 (en) | 1999-04-09 | 2013-10-15 | Faezeh Mona Sarfarazi | Interior bag for a capsular bag and injector |
US6488708B2 (en) | 1999-04-09 | 2002-12-03 | Faezeh Sarfarazi | Open chamber, elliptical, accommodative intraocular lens system |
US6235055B1 (en) | 1999-08-09 | 2001-05-22 | Milton W. Chu | Intraocular lens having colored haptics for anterior/posterior orientation, and method for implanting it |
US6217612B1 (en) | 1999-09-10 | 2001-04-17 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6299641B1 (en) | 1999-09-10 | 2001-10-09 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6280471B1 (en) | 1999-09-16 | 2001-08-28 | Gholam A. Peyman | Glare-free intraocular lens and method for using the same |
US6645246B1 (en) | 1999-09-17 | 2003-11-11 | Advanced Medical Optics, Inc. | Intraocular lens with surrounded lens zone |
FR2799637B1 (fr) | 1999-10-13 | 2002-04-12 | Ioltechnologie Production | Implant intraoculaire prismatique pour chambre posterieure de l'oeil |
US20010051825A1 (en) | 1999-12-27 | 2001-12-13 | Peterson Norman D. | Temporary lenses and method for providing correct lens power |
AU2001225434A1 (en) | 2000-02-03 | 2001-08-14 | Accommo Ag | Lens implant |
US20050085907A1 (en) | 2000-02-16 | 2005-04-21 | Humanoptics Ag | Intraocular implant and an artificial lens device |
FR2804860B1 (fr) | 2000-02-16 | 2002-04-12 | Humanoptics Ag | Implant cristallinien accomodatif |
US6797004B1 (en) | 2000-03-02 | 2004-09-28 | Advanced Medical Optics, Inc. | Holders for intraocular lenses |
US20010047204A1 (en) | 2000-03-20 | 2001-11-29 | Medennium, Inc. | Method for determination of a properly sized posterior chamber phakic refractive lens |
US8162927B2 (en) | 2000-03-21 | 2012-04-24 | Gholam A. Peyman | Method and apparatus for accommodating intraocular lens |
US6949093B1 (en) | 2000-03-21 | 2005-09-27 | Minu, L.L.C. | Adjustable universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith |
US20120226351A1 (en) | 2000-03-21 | 2012-09-06 | Peyman Gholam A | Accommodating intraocular lens |
US20050113911A1 (en) | 2002-10-17 | 2005-05-26 | Peyman Gholam A. | Adjustable intraocular lens for insertion into the capsular bag |
US20040208910A1 (en) * | 2000-04-26 | 2004-10-21 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
US6413276B1 (en) | 2000-04-26 | 2002-07-02 | Emmetropia, Inc. | Modified intraocular lens and method of correcting optical aberrations therein |
US6537317B1 (en) | 2000-05-03 | 2003-03-25 | Advanced Medical Optics, Inc. | Binocular lens systems |
US6506212B2 (en) * | 2000-07-07 | 2003-01-14 | Medennium, Inc. | Anatomically compatible posterior chamber phakic refractive lenses |
WO2002009619A2 (en) | 2000-07-28 | 2002-02-07 | Kiyoshi Okada | Intraocular lenses with reduced complications |
JP2004513383A (ja) | 2000-09-26 | 2004-04-30 | カルホーン ビジョン インコーポレーテッド | 調整可能なレンズのパワー調整 |
US6721043B2 (en) | 2000-10-11 | 2004-04-13 | Calhoun Vision, Inc. | Light adjustable aberration conjugator |
US6596026B1 (en) | 2000-11-27 | 2003-07-22 | Visioncare Ophthalmic Technologies, Inc. | Telescopic intraocular lens |
US6464725B2 (en) | 2001-01-23 | 2002-10-15 | Bernt Christian Skotton | Two-lens adjustable intraocular lens system |
US6761737B2 (en) | 2001-01-25 | 2004-07-13 | Visiogen, Inc. | Translation member for intraocular lens system |
US20030078658A1 (en) | 2001-01-25 | 2003-04-24 | Gholam-Reza Zadno-Azizi | Single-piece accomodating intraocular lens system |
US7198640B2 (en) | 2001-01-25 | 2007-04-03 | Visiogen, Inc. | Accommodating intraocular lens system with separation member |
US6884261B2 (en) | 2001-01-25 | 2005-04-26 | Visiogen, Inc. | Method of preparing an intraocular lens for implantation |
US20030078657A1 (en) | 2001-01-25 | 2003-04-24 | Gholam-Reza Zadno-Azizi | Materials for use in accommodating intraocular lens system |
WO2002071983A1 (en) | 2001-01-25 | 2002-09-19 | Gholam-Reza Zadno-Azizi | Accommodating intraocular lens system |
US7780729B2 (en) | 2004-04-16 | 2010-08-24 | Visiogen, Inc. | Intraocular lens |
US8062361B2 (en) | 2001-01-25 | 2011-11-22 | Visiogen, Inc. | Accommodating intraocular lens system with aberration-enhanced performance |
US6818158B2 (en) | 2001-01-25 | 2004-11-16 | Visiogen, Inc. | Accommodating intraocular lens system and method of making same |
US6827738B2 (en) | 2001-01-30 | 2004-12-07 | Timothy R. Willis | Refractive intraocular implant lens and method |
AU2002240147A1 (en) | 2001-02-01 | 2002-08-12 | Tekia, Inc. | Two part "l"- or "s"-shaped phakic iol |
US6713081B2 (en) * | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
US20040167622A1 (en) | 2001-03-26 | 2004-08-26 | Sunalp Murad A. | Temporary refractive intraocular lens and methods of use |
US6576012B2 (en) | 2001-03-28 | 2003-06-10 | Advanced Medical Optics, Inc. | Binocular lens systems |
US6524340B2 (en) | 2001-05-23 | 2003-02-25 | Henry M. Israel | Accommodating intraocular lens assembly |
US6884263B2 (en) | 2001-07-17 | 2005-04-26 | Medennium, Inc. | Accommodative intraocular lens |
JP4249611B2 (ja) * | 2001-07-23 | 2009-04-02 | アルコン,インコーポレイティド | 眼薬剤送致装置 |
US6443985B1 (en) | 2001-08-27 | 2002-09-03 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6533813B1 (en) | 2001-09-07 | 2003-03-18 | Chwen Yih Lin | Intraocular lens that may accommodate automatically |
GB0126234D0 (en) | 2001-11-01 | 2002-01-02 | Khoury Elie | Intraocular lens implant having accommodative capabilities |
US7241009B2 (en) | 2001-11-21 | 2007-07-10 | Calhoun Vision, Inc. | Crosslinking of silicones presence of functionalized silicones |
US7037338B2 (en) * | 2001-12-14 | 2006-05-02 | Toshiyuki Nagamoto | Intraocular ring assembly and artificial lens kit |
US6851804B2 (en) | 2001-12-28 | 2005-02-08 | Jagdish M. Jethmalani | Readjustable optical elements |
US7237893B2 (en) | 2001-12-28 | 2007-07-03 | Chang Shiao H | Light adjustable lenses capable of post-fabrication power modification via multi-photon processes |
US20030176521A1 (en) | 2001-12-28 | 2003-09-18 | Calhoun Vision | Initiator and ultraviolet absorber for changing lens power by ultraviolet light |
US7560499B2 (en) | 2001-12-28 | 2009-07-14 | Calhoun Vision, Inc. | Initiator and ultraviolet absorber blends for changing lens power by ultraviolet light |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
WO2003059208A2 (en) | 2002-01-14 | 2003-07-24 | Advanced Medical Optics, Inc. | Accommodating intraocular lens with integral capsular bag ring |
WO2003061625A2 (en) * | 2002-01-18 | 2003-07-31 | Snyder Michael E | Sustained release ophthalmological device and method of making and using the same |
US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
CN1638743B (zh) | 2002-03-11 | 2012-11-07 | 爱尔康公司 | 可植入药物的释放系统 |
US20030187505A1 (en) | 2002-03-29 | 2003-10-02 | Xiugao Liao | Accommodating intraocular lens with textured haptics |
US20040158322A1 (en) | 2002-04-17 | 2004-08-12 | Shen Jin Hui | Intraocular lens system |
US6695881B2 (en) | 2002-04-29 | 2004-02-24 | Alcon, Inc. | Accommodative intraocular lens |
US20070123767A1 (en) | 2002-05-31 | 2007-05-31 | Valentino Montegrande | Intraocular pressure sensor and method of use |
US6972033B2 (en) | 2002-08-26 | 2005-12-06 | Advanced Medical Optics, Inc. | Accommodating intraocular lens assembly with multi-functional capsular bag ring |
US20040064182A1 (en) | 2002-09-26 | 2004-04-01 | Kelman Charles David | High-myopia anterior chamber lens of one-piece, foldable construction |
US7125422B2 (en) | 2002-10-25 | 2006-10-24 | Quest Vision Technology, Inc. | Accommodating intraocular lens implant |
US20040082993A1 (en) | 2002-10-25 | 2004-04-29 | Randall Woods | Capsular intraocular lens implant having a refractive liquid therein |
US20040082995A1 (en) | 2002-10-25 | 2004-04-29 | Randall Woods | Telescopic intraocular lens implant for treating age-related macular degeneration |
US6991651B2 (en) | 2002-11-27 | 2006-01-31 | Valdemar Portney | Adjustable intraocular lens system and intraocular lenses therefor |
EP1585563A4 (en) | 2002-12-12 | 2012-03-21 | Powervision Inc | ACCOMODING INTRAOCULAR LENS SYSTEM AND METHOD |
US7001427B2 (en) | 2002-12-17 | 2006-02-21 | Visioncare Ophthalmic Technologies, Inc. | Intraocular implants |
US20040254438A1 (en) | 2003-01-09 | 2004-12-16 | The Regents Of The University Of California | Implantable devices and methods for measuring intraocular, subconjunctival or subdermal pressure and/or analyte concentration |
US6972032B2 (en) | 2003-01-14 | 2005-12-06 | Visioncare Ophthalmic Technologies Inc. | Intraocular lens implant |
US7556378B1 (en) | 2003-04-10 | 2009-07-07 | Tsontcho Ianchulev | Intraoperative estimation of intraocular lens power |
ES2344939T3 (es) | 2003-05-07 | 2010-09-10 | Visioncare Ophthalmic Technologies, Inc. | Lente intraocular telescopica. |
US7223288B2 (en) | 2003-05-21 | 2007-05-29 | Alcon, Inc. | Accommodative intraocular lens |
US7029497B2 (en) | 2003-05-21 | 2006-04-18 | Alcon, Inc. | Accommodative intraocular lens |
US6960231B2 (en) | 2003-07-14 | 2005-11-01 | Alcon, Inc. | Intraocular lens system |
JP2007501794A (ja) | 2003-08-08 | 2007-02-01 | カルホーン ビジョン | 多光子過程により製造後の度数変更が可能な光により調整可能なレンズ |
US7144423B2 (en) | 2003-11-12 | 2006-12-05 | Mcdonald Marguerite B | Intraocular multifocal lens |
US20050131534A1 (en) | 2003-11-14 | 2005-06-16 | Rozakis George W. | Posterior chamber phakic intraocular lens |
JP2005143886A (ja) | 2003-11-17 | 2005-06-09 | Juneki Rin | 自動調整可能な人工水晶体 |
FR2862524A1 (fr) * | 2003-11-21 | 2005-05-27 | Jacques Duvert | Implant oculaire pour la correction des defauts de la vision |
US20050137703A1 (en) | 2003-12-05 | 2005-06-23 | Vanderbilt University | Accommodative intraocular lens |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
WO2005094727A1 (en) | 2004-03-02 | 2005-10-13 | Cardiomind Inc. | Electrolytic stent delivery systems |
US7150760B2 (en) * | 2004-03-22 | 2006-12-19 | Alcon, Inc. | Accommodative intraocular lens system |
US8535331B2 (en) | 2004-03-31 | 2013-09-17 | Bausch & Lomb Incorporated | IOL injector |
US9713527B2 (en) | 2004-04-30 | 2017-07-25 | Rxsight, Inc. | Multilens intraocular lens system with injectable accommodation material |
US9005282B2 (en) | 2004-04-30 | 2015-04-14 | Calhoun Vision, Inc. | Intraocular lens system with injectable accommodation material |
WO2005107649A2 (en) | 2004-04-30 | 2005-11-17 | Calhoun Vision, Inc. | Injectable accommodation composition |
US7771319B1 (en) | 2004-05-10 | 2010-08-10 | Michael G. Lannon | Exercising apparatus |
WO2006014738A2 (en) | 2004-07-22 | 2006-02-09 | Cornell Research Foundation, Inc. | Accommodating intraocular lens and methods of use |
WO2006015315A2 (en) | 2004-07-30 | 2006-02-09 | University Of Rochester Medical Center | Intraocular video system |
US20060027939A1 (en) | 2004-08-03 | 2006-02-09 | Axel Brait | Method for making novel compositions capable of post fabrication modification |
US7806929B2 (en) | 2004-08-27 | 2010-10-05 | Brown David C | Intracapsular pseudophakic device |
US7435258B2 (en) | 2004-09-17 | 2008-10-14 | Blake Larry W | Accommodating intraocular lens device |
US7300464B2 (en) | 2004-09-30 | 2007-11-27 | Alcon, Inc. | Intraocular lens |
US9872763B2 (en) | 2004-10-22 | 2018-01-23 | Powervision, Inc. | Accommodating intraocular lenses |
EP3195831B1 (en) | 2004-11-02 | 2023-09-13 | e-Vision Smart Optics Inc. | Electro-active lenses |
US8931896B2 (en) | 2004-11-02 | 2015-01-13 | E-Vision Smart Optics Inc. | Eyewear including a docking station |
US8778022B2 (en) | 2004-11-02 | 2014-07-15 | E-Vision Smart Optics Inc. | Electro-active intraocular lenses |
CA2601351A1 (en) | 2005-03-30 | 2006-10-05 | Nulens Ltd | Accommodating intraocular lens (aiol) assemblies, and discrete components therfor |
EP1906881B1 (en) | 2005-05-11 | 2012-08-15 | McDonald, Marguerite, B. | Intraocular multifocal lens |
US7771471B2 (en) | 2005-05-13 | 2010-08-10 | C & C Vision International Limited | Floating optic accommodating intraocular lens |
US20070010881A1 (en) | 2005-07-11 | 2007-01-11 | Alcon, Inc. | Intraocular lens system |
US20120179249A1 (en) | 2005-07-21 | 2012-07-12 | Cornell University | Accommodating intraocular lens and methods of use |
US20070027541A1 (en) * | 2005-07-26 | 2007-02-01 | Visioncare Ophthalmic Technologies Inc. | Intraocular devices and methods for implantation thereof |
US8088161B2 (en) | 2005-07-28 | 2012-01-03 | Visioncare Ophthalmic Technologies Inc. | Compressed haptics |
US20070032868A1 (en) | 2005-08-08 | 2007-02-08 | Randall Woods | Capsular shape-restoring device |
US7316713B2 (en) | 2005-08-29 | 2008-01-08 | Alcon, Inc. | Accommodative intraocular lens system |
US8034107B2 (en) | 2005-09-01 | 2011-10-11 | Stenger Donald C | Accommodating intraocular lens |
US9629712B2 (en) | 2005-09-01 | 2017-04-25 | Donald C. Stenger | Accommodating intraocular lens |
WO2007030799A2 (en) | 2005-09-08 | 2007-03-15 | Calhoun Vision, Inc. | Novel adjustable optical elements with enhanced ultraviolet protection |
US20070083261A1 (en) | 2005-10-07 | 2007-04-12 | Colvard David M | Method of maintaining the preoperative dimensions of the eye in an intraocular lens placement procedure |
US20070093892A1 (en) | 2005-10-20 | 2007-04-26 | Alcon Manufacturing, Ltd. | Maintaining preoperative position of the posterior lens capsule after cataract surgery |
US8241355B2 (en) | 2005-10-28 | 2012-08-14 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
US20070118216A1 (en) | 2005-11-21 | 2007-05-24 | Joel Pynson | Accommodative intraocular lens |
EP1981436B1 (en) | 2006-01-17 | 2020-12-09 | Minas Theodore Coroneo | A capsular implant for maintaining the shape and/or position of an opening formed by capsulorhexis |
US7837730B2 (en) | 2006-02-21 | 2010-11-23 | C & C International Limited | Floating optic accommodating intraocular lens |
US20070244560A1 (en) | 2006-04-12 | 2007-10-18 | Alexei Ossipov | Intraocular lens with distortion free valve |
US20070260308A1 (en) | 2006-05-02 | 2007-11-08 | Alcon, Inc. | Accommodative intraocular lens system |
US8197539B2 (en) * | 2006-05-05 | 2012-06-12 | University Of Southern California | Intraocular camera for retinal prostheses |
US20080097599A1 (en) | 2006-10-19 | 2008-04-24 | Rozakis George W | Posterior chamber Phakic Intraocular Lens |
US7813047B2 (en) | 2006-12-15 | 2010-10-12 | Hand Held Products, Inc. | Apparatus and method comprising deformable lens element |
EP2124822B1 (en) * | 2006-12-22 | 2019-02-20 | AMO Groningen B.V. | Accommodating intraocular lens, lens system and frame therefor |
US7713299B2 (en) * | 2006-12-29 | 2010-05-11 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
US8048156B2 (en) | 2006-12-29 | 2011-11-01 | Abbott Medical Optics Inc. | Multifocal accommodating intraocular lens |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US8608799B2 (en) * | 2007-01-24 | 2013-12-17 | Tekia, Inc. | Umbrella-shaped accommodating artificial ocular lens (AAOL) device |
US9398949B2 (en) * | 2007-01-29 | 2016-07-26 | Emmetropia, Inc. | Intraocular lens system |
US7811320B2 (en) | 2007-01-29 | 2010-10-12 | Werblin Research & Development Corp. | Intraocular lens system |
EP2120789B1 (en) | 2007-03-05 | 2010-10-06 | Nulens Ltd | Unitary accommodating intraocular lenses (aiols) and discrete base members for use therewith |
WO2008112292A1 (en) | 2007-03-13 | 2008-09-18 | Optimedica Corporation | Apparatus for creating ocular surgical and relaxing incisions |
WO2009021327A1 (en) | 2007-08-13 | 2009-02-19 | Webb Garth T | Inflatable intra ocular lens/lens retainer |
ES2711908T3 (es) | 2007-10-15 | 2019-05-08 | Akkolens Int B V | Lente intraocular acomodativa ajustable y medios de posicionamiento |
US20090182423A1 (en) * | 2008-01-16 | 2009-07-16 | Lei Zheng | Crystalline lens capsular support device for use in a surgical procedure on a human eye |
EP2294473A1 (fr) | 2008-05-19 | 2011-03-16 | Ice Foster Limited | Verre ophtalmique et lunettes comprenant au moins un tel verre |
JP4308307B1 (ja) * | 2008-05-30 | 2009-08-05 | 章弘 小栗 | 水晶体嚢構成体 |
KR20100004777A (ko) | 2008-07-04 | 2010-01-13 | 김현호 | 인공수정체 및 인공수정체의 수술후 굴절오차 보정 방법 |
US8398709B2 (en) | 2008-07-24 | 2013-03-19 | Nulens Ltd. | Accommodating intraocular lens (AIOL) capsules |
US8551167B2 (en) | 2008-11-20 | 2013-10-08 | Insight Innovations, Llc | Intraocular implant cell migration inhibition system |
US8728158B2 (en) | 2009-02-09 | 2014-05-20 | Jeffrey C. Whitsett | Exchangeable intraocular lens device and method of use |
US9078744B2 (en) | 2009-02-11 | 2015-07-14 | Novartis Ag | Single optic accommodative intraocular lens system |
WO2010151693A2 (en) * | 2009-06-26 | 2010-12-29 | Abbott Medical Optics Inc. | Accommodating intraocular lenses |
EP2453822B1 (en) | 2009-07-14 | 2014-08-20 | WaveTec Vision Systems, Inc. | Determination of the effective lens position of an intraocular lens using aphakic refractive power |
WO2011062826A2 (en) | 2009-11-17 | 2011-05-26 | Lu Kenneth L | Accommodating intraocular lens |
MX2012006940A (es) | 2009-12-18 | 2012-07-17 | Novartis Ag | Dispoitivos intraoculares y metodos asociados. |
GB2476480B (en) | 2009-12-22 | 2013-04-03 | Marwan Ghabra | Intraocular implant with a fixed and a pivoting lens |
US8821166B2 (en) | 2010-04-09 | 2014-09-02 | Frontier Vision Co., Ltd. | Artificial lens for cataract surgery practice |
WO2011146483A1 (en) * | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
CN103037790A (zh) | 2010-06-20 | 2013-04-10 | 伊兰扎公司 | 具有专用集成电路的眼科装置和方法 |
US20110313521A1 (en) | 2010-06-21 | 2011-12-22 | Angelopoulos Robert D | Intraocular rings and associated systems and methods |
FR2963229B1 (fr) | 2010-07-27 | 2013-07-12 | Philippe Sourdille | Implant intraoculaire a elements d'accrochage. |
CN103025271A (zh) | 2010-08-15 | 2013-04-03 | 纽镜有限公司 | 分离的预组装的整体的aiol组合件和包括同样组合件的aiol组件 |
US20120238857A1 (en) | 2010-09-16 | 2012-09-20 | Orthomems, Inc. | Expandable implantable pressure sensor for intraocular surgery |
EP3427693B1 (en) | 2010-09-30 | 2020-06-24 | KeraMed, Inc. | Reversibly deformable artificial cornea |
WO2012054402A2 (en) | 2010-10-18 | 2012-04-26 | University Of Utah Research Foundation | Vision correction system |
FR2966340A1 (fr) | 2010-10-20 | 2012-04-27 | Jacques Duvert | Implant artificiel intra-oculaire pour la correction de tous les defauts de vision de l'oeil et supprimer les lunettes de vue |
JP2014504171A (ja) | 2010-11-15 | 2014-02-20 | エレンザ, インコーポレイテッド | 適合可能な眼内レンズ |
JP6023799B2 (ja) | 2011-05-23 | 2016-11-09 | カリフォルニア インスティチュート オブ テクノロジー | 調節性眼内レンズ |
US9186243B2 (en) | 2011-05-31 | 2015-11-17 | Novartis Ag | Accommodative intraocular lens and method of implantation |
US10874505B2 (en) | 2011-09-16 | 2020-12-29 | Rxsight, Inc. | Using the light adjustable lens (LAL) to increase the depth of focus by inducing targeted amounts of asphericity |
US8574295B2 (en) | 2012-01-17 | 2013-11-05 | Vista Ocular, Llc | Accommodating intra-ocular lens system |
EP3915519A1 (en) | 2012-01-24 | 2021-12-01 | The Regents of the University of Colorado, a body corporate | Modular intraocular lens designs |
US10080648B2 (en) | 2012-01-24 | 2018-09-25 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US10028824B2 (en) | 2012-01-24 | 2018-07-24 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US9364316B1 (en) | 2012-01-24 | 2016-06-14 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US8900300B1 (en) | 2012-02-22 | 2014-12-02 | Omega Ophthalmics Llc | Prosthetic capsular bag and method of inserting the same |
JP2015515321A (ja) | 2012-04-06 | 2015-05-28 | エレンザ, インコーポレイテッド | インプラント可能な眼下用デバイスの電力管理のためのシステムおよび方法 |
WO2013158942A1 (en) | 2012-04-20 | 2013-10-24 | Hanita Lenses R.C.A. Ltd. | Intraocular assembly |
US20130304206A1 (en) * | 2012-05-10 | 2013-11-14 | Ioannis Pallikaris | Intraocular Device to Restore Natural Capsular Tension after Cataract Surgery |
DE102012016893A1 (de) | 2012-08-24 | 2014-05-15 | Be Innovative Gmbh | Intraokularlinse, insbesondere Kapselsackintraokularlinse |
ES2457840B1 (es) | 2012-09-28 | 2015-02-16 | Universidad De Murcia | Lente intraocular acomodativa de potencia variable y conjunto de lente intraocular acomodativa de potencia variable y anillo capsular |
US9339375B2 (en) | 2012-12-17 | 2016-05-17 | Novartis Ag | Capsule expander devices, systems, and methods for inhibiting capsular opacification and stabilizing the capsule |
KR20150100645A (ko) | 2012-12-21 | 2015-09-02 | 노바르티스 아게 | 곡률 변화 조절성 안구내 렌즈 |
US10258462B2 (en) | 2012-12-26 | 2019-04-16 | Rainbow Medical Ltd. | Accommodative intraocular lens |
EP2939636A4 (en) | 2012-12-26 | 2016-08-31 | Frontier Vision Co Ltd | CRYSTALLOID EXTENSION DEVICE |
US9486311B2 (en) | 2013-02-14 | 2016-11-08 | Shifamed Holdings, Llc | Hydrophilic AIOL with bonding |
EP2945571B1 (en) | 2013-02-28 | 2018-04-25 | HONIGSBAUM, Richard F. | Tensioning rings for anterior capsules and accommodative intraocular lenses for use therewith |
US10058343B2 (en) | 2013-03-14 | 2018-08-28 | Covidien Lp | Systems for performing endoscopic procedures |
US10195018B2 (en) | 2013-03-21 | 2019-02-05 | Shifamed Holdings, Llc | Accommodating intraocular lens |
BR112015024156A2 (pt) | 2013-03-21 | 2017-07-18 | Shifamed Holdings Llc | lente intraocular de acomodação |
IN2013MU01353A (ja) | 2013-04-10 | 2015-09-25 | Polymer Technologies Internat Eou | |
US9897824B2 (en) | 2013-05-17 | 2018-02-20 | Johnson & Johnson Vision Care, Inc. | Method and device for monitoring ophthalmic lens manufacturing conditions |
ES2955193T3 (es) | 2013-06-03 | 2023-11-29 | Alcon Inc | Diseños de lentes intraoculares modulares |
US20140371852A1 (en) | 2013-06-16 | 2014-12-18 | Eli Aharoni | Scleral fixation bag |
CN103340703A (zh) | 2013-06-17 | 2013-10-09 | 无锡蕾明视康科技有限公司 | 一种植入性近视眼透镜片及其制备方法 |
US9170646B2 (en) | 2013-09-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens system capable of interfacing with an external device |
EP2851038A1 (en) | 2013-09-24 | 2015-03-25 | Consejo Superior De Investigaciones Cientificas | Intraocular lens with accomodation capacity |
US20150100046A1 (en) | 2013-10-09 | 2015-04-09 | Balamurali K. Ambati | Intraocular drug delivery device and associated methods |
DE202013009162U1 (de) | 2013-10-17 | 2013-11-13 | Oculentis Holding B.V. | Intraokularlinsen-Baugruppe |
US9173527B2 (en) | 2013-10-22 | 2015-11-03 | Belle-V, LLC | Ice cream scoop |
WO2015066502A1 (en) | 2013-11-01 | 2015-05-07 | Thomas Silvestrini | Accomodating intraocular lens device |
EP3977962A1 (en) | 2013-11-01 | 2022-04-06 | Lensgen, Inc. | Two-part accomodating intraocular lens device |
JP6191821B2 (ja) | 2013-11-06 | 2017-09-06 | Nok株式会社 | 定着加圧ロール及び定着装置 |
US9662199B2 (en) * | 2013-11-26 | 2017-05-30 | Strathspey Crown Holdings, LLC | Intraocular lens having input and output electronics |
EP3081193A4 (en) | 2013-12-13 | 2017-08-16 | Xlens Technologies Inc. | Adjustible intraocular lens |
AU2015219461B2 (en) | 2014-02-18 | 2019-10-31 | Alcon Inc. | Modular intraocular lens designs, tools and methods |
US20150272727A1 (en) | 2014-03-27 | 2015-10-01 | Mark Humayun | Intraocular lens with coupling features |
NL1040788B1 (en) | 2014-05-01 | 2016-07-13 | Fugro Tech Bv | Optical fiber sensor assembly. |
CA2952809C (en) | 2014-06-19 | 2019-11-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
EP3160404B1 (en) | 2014-06-24 | 2022-03-16 | Rainbow Medical Ltd. | Accommodative intraocular lens |
US9579427B2 (en) | 2014-06-28 | 2017-02-28 | Cordis Corporation | Thin-film composite retrievable endovascular devices and method of use |
US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
US20160030163A1 (en) | 2014-07-31 | 2016-02-04 | Art, Limited | Surgical Apparatus and Method Of Implanting The Same |
US10314691B2 (en) | 2014-10-24 | 2019-06-11 | Verily Life Sciences Llc | Intra-ocular device |
EP3250152A1 (en) | 2015-01-30 | 2017-12-06 | Clarvista Medical, Inc. | Modular intraocular lens designs |
US9744030B2 (en) | 2015-02-04 | 2017-08-29 | Novartis Ag | Capsular ring with improved fixation and centering |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
BR112017009900A2 (pt) | 2015-05-20 | 2017-12-26 | Rxsight Inc | método para modificar a potência de lente ajustável com luz |
KR101718075B1 (ko) | 2015-05-29 | 2017-04-04 | 주식회사 로섹 | 안구내 렌즈 조립체 |
US10799340B2 (en) | 2015-08-10 | 2020-10-13 | Alcon Inc. | Intraocular lens having a capsular ring for inhibiting capsular opacification |
WO2017030582A1 (en) | 2015-08-19 | 2017-02-23 | Cherne Scott A | Intraocular lens holder |
US20170049560A1 (en) | 2015-08-21 | 2017-02-23 | Scott A. Cherne | Intraocular Lens Holder |
CA3002085A1 (en) | 2015-11-04 | 2017-05-11 | The Regents Of The University Of Colorado, A Body Corporate | Modular intraocular lens designs, tools and methods |
WO2017109624A1 (en) | 2015-12-22 | 2017-06-29 | Novartis Ag | Accommodating intraocular lens |
US11045309B2 (en) | 2016-05-05 | 2021-06-29 | The Regents Of The University Of Colorado | Intraocular lens designs for improved stability |
US10327886B2 (en) | 2016-06-01 | 2019-06-25 | Rainbow Medical Ltd. | Accomodative intraocular lens |
WO2017213980A1 (en) | 2016-06-06 | 2017-12-14 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
CA3040281C (en) | 2016-10-21 | 2021-04-13 | Omega Ophthalmics Llc | Prosthetic capsular devices |
US11213384B2 (en) | 2017-03-01 | 2022-01-04 | Eye-Pcr B.V. | Devices for reconstruction of a lens capsule after cataract surgery |
AU2019249216B2 (en) | 2018-04-06 | 2024-07-18 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
WO2019236908A1 (en) | 2018-06-07 | 2019-12-12 | Lensgen, Inc. | Intraocular lens devices and related methods |
EP4225211A1 (en) | 2020-10-12 | 2023-08-16 | Omega Ophthalmics LLC | Prosthetic capsular devices, systems, and methods |
-
2015
- 2015-12-14 US US14/968,427 patent/US9358103B1/en active Active
- 2015-12-15 CA CA2972030A patent/CA2972030C/en active Active
- 2015-12-15 WO PCT/US2015/065887 patent/WO2016130209A1/en active Application Filing
- 2015-12-15 EP EP15882268.4A patent/EP3256072A4/en active Pending
- 2015-12-15 CA CA3121752A patent/CA3121752A1/en not_active Abandoned
- 2015-12-15 JP JP2017542011A patent/JP6499307B2/ja active Active
- 2015-12-15 AU AU2015382334A patent/AU2015382334B2/en active Active
-
2016
- 2016-04-26 US US15/138,679 patent/US9517127B2/en active Active
- 2016-05-17 US US15/157,015 patent/US9504558B2/en active Active
- 2016-05-17 US US15/156,999 patent/US9554890B2/en active Active
- 2016-05-17 US US15/156,904 patent/US9597176B2/en active Active
- 2016-05-17 US US15/157,089 patent/US9522060B2/en active Active
- 2016-05-17 US US15/156,980 patent/US9522059B2/en active Active
-
2017
- 2017-01-25 US US15/414,964 patent/US9763771B1/en active Active
- 2017-08-14 US US15/676,101 patent/US9925037B2/en active Active
-
2018
- 2018-02-13 US US15/895,964 patent/US10743983B2/en active Active
- 2018-06-08 AU AU2018204135A patent/AU2018204135B2/en active Active
- 2018-11-30 AU AU2018271403A patent/AU2018271403B2/en active Active
-
2019
- 2019-03-14 JP JP2019046962A patent/JP2019130329A/ja active Pending
- 2019-05-17 AU AU2019203495A patent/AU2019203495B2/en active Active
-
2020
- 2020-04-22 AU AU2020202696A patent/AU2020202696B2/en active Active
- 2020-07-10 US US16/926,419 patent/US11213381B2/en active Active
-
2021
- 2021-11-09 US US17/454,145 patent/US11638641B2/en active Active
-
2023
- 2023-03-20 US US18/186,826 patent/US12042374B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357620B1 (en) | 2021-09-10 | 2022-06-14 | California LASIK & Eye, Inc. | Exchangeable optics and therapeutics |
US11974911B2 (en) | 2021-09-10 | 2024-05-07 | California LASIK & Eye, Inc. | Exchangeable optics and therapeutics |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6499307B2 (ja) | 人工カプセルデバイス、システム、および方法 | |
US10813745B2 (en) | Prosthetic capsular devices, systems, and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180305 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180828 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180831 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181122 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190212 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190314 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6499307 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |